##semicolon##
adrenal glands, adrenal incidentalomas, adrenal gland tumors, diagnostic imaging of adrenal gland.##submission.citations##
Albano D, Agnello F, Midiri F, et al. Imaging features of adrenal masses. Insights Imaging. 2019;10(1):1. https://doi.org/10.1186/s13244-019-0688-8
Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands? J Endocrinol Invest. 2020;43(8):1169-1170. https:// doi.org/10.1007/s40618-020-01311-8
Boland GW, Dwamena BA, Jagtiani Sangwaiya M. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259(1):117-126. https://doi.org/10.1148/radiol.11100569
Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006;29(4):298-302. https:// doi.org/10.1007/BF03344099
d’Amuri FV, Maestroni U, Pagnini F, et al. Magnetic resonance imaging of adrenal gland: state of the art. Gland Surg. 2019;8(3):223-232. https://doi.org/10.21037/gs.2019.06.02
Delivanis DA, Bancos I, Atwell TD, et al. Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours. Clin Endocrinol (Oxf). 2018;88(1):30-36. https://doi.org/10.1111/cen.13448
Dietrich CF, Ignee A, Barreiros AP, et al. Contrast-enhanced ultrasound for imaging of adrenal masses. Ultraschall Med. 2010;31(2):163-168. https://doi.org/10.1055/s-0028-1109357
Elmohr MM, Fuentes D, Habra MA, et al. Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT. Clin Radiol. 2019;74(10):818-818. https://doi.org/10.1016/j.crad.2019.06.021
Fassnacht M, Assie G, Baudin E, et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1476-1490. https://doi.org/10.1016/j.annonc.2020.08.2099
Fassnacht M, Dekkers OM, Else T, et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4):G1-G46. https://doi.org/10.1530/EJE-18-0608
Folligan K, Bouvier R, Targe F, et al. Le développement de la surrénale humaine [Deve-lopment of the human adrenal glands]. Ann Endocrinol (Paris). 2005;66(4):325-332. https://doi.org/ 10.1016/s0003-4266(05)81789-5
Friedrich-Rust M, Glasemann T, Polta A, et al. Differentiation between benign and malig-nant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med. 2011;32(5):460-471. https://doi.org/10.1055/s-0031-1273408
Jenssen C, Dietrich CF. Sonografie und Endosonografie der Nebennieren [Ultrasound and endoscopic ultrasound of the adrenal glands]. Ultraschall Med. 2010;31(3):228-247. -https://doi.org/ 10.1055/s-0029-1245449
Kandathil A, Wong KK, Wale DJ, et al. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature. Endocrine. 2015;49(1):6-26. https://doi.org/10.1007/s12020-014-0440-6
Korivi BR, Elsayes KM, de Castro SF, et al. An Update of Practical CT Adrenal Imaging: What Physicians Need to Know. Curr Radiol Rep. 2015;3(4):12. https://doi.org/10.1007/s40134-015-0091-2
Mayo-Smith WW, Song JH, Boland GL, et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017;14(8):1038-1044. https://doi.org/10.1016/j.jacr.2017.05.001
Nagayama Y, Inoue T, Oda S, et al. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps. Radiology. 2020;296(2):324-332. https://doi.org/10.1148/radiol.2020192227
Nakajo M, Jinguji M, Nakajo M, et al. Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: efficacy of combining SUV and texture parameters. Abdom Radiol (NY). 2017;42(12):2882-2889. https://doi.org/10.1007/s00261-017-1207-3
Nguyen XV, Davies L, Eastwood JD, Hoang JK. Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial. J Am Coll Radiol. 2017;14(3):324-330. https://doi.org/10.1016/j.jacr.2016.09.044
Peña CS, Boland GW, Hahn PF, et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology.2000;217(3):798-802. https://doi.org/10.1148/radiology.217.3.r00dc29 798
Sangwaiya MJ, Boland GW, Cronin CG, et al. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort. Radiology. 2010;256(2):504-510. https://doi.org/10.1148/ radiol.10091386
Schieda N, Krishna S, McInnes MDF, et al. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas. AJR Am J Roentgenol. 2017; 209(3):152-159. https://doi.org/10.2214/AJR.16. 17649
Sebro R, Aslam R, Muglia VF, et al. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT. Abdom Imaging. 2015;40(2):318-326. https://doi.org/10.1007/s00261-014-0208-8
Seo JM, Park BK, Park SY, Kim CK. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol. 2014;202(5):1043-1050. https://doi.org /10.2214/AJR.13.11389
Słapa RZ, Jakubowski WS, Dobruch-Sobczak K, et al. Standards of ultrasound imaging of the adrenal glands. J Ultrason. 2015;15(63):377-387. https://doi.org/10.15557/JoU.2015.0035
Slapa RZ, Kasperlik-Zaluska AA, Migda B, et al. Application of parametric ultrasound contrast agent perfusion studies for differentiation of hyperplastic adrenal nodules from adenomas-Initial study. Eur J Radiol. 2015;84(8):1432-1435. https://doi.org/10.1016/j.ejrad.2015.05.006
Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163-1168. https://doi.org/10.2214/AJR.07.2799
Tallis PH, Rushworth RL, Torpy DJ, Falhammar H. Adrenal insufficiency due to bilateral adrenal metastases - A systematic review and meta-analysis. Heliyon. 2019;5(5):e01783. https:// doi.org/10.1016/j.heliyon. 2019.e01783
Wu Q, Luo W, Zhao Y, et al. The utility of 18F-FDG PET/CT for the diagnosis of adrenal metastasis in lung cancer: a PRISMA-compliant meta-analysis. Nucl Med Commun. 2017;38(12): 1117-1124. https://doi.org/10.1097/MNM.0000000000000757
Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356(6):601-610. https://doi.org/10.1056/NEJMcp065470
Yu H, Parakh A, Blake M, McDermott S. Texture Analysis as a Radiomic Marker for Differentiating Benign From Malignant Adrenal Tumors. J Comput Assist Tomogr. 2020;44(5):766-771. https://doi.org/10.1097/RCT.00000000000 01051
Zhang GM, Shi B, Sun H, et al. Differentiating pheochromocytoma from lipid-poor adrenocortical adenoma by CT texture analysis: feasibility study. Abdom Radiol (NY). 2017;42(9): 2305-2313. https://doi.org/10.1007/s00261-017-1118-3